Information about eyeonvegf-a.org (Lucentis® (ranibizumab injection) for Wet AMD, Diabetic Macular Edema (DME) & Macular Edema following Retinal Vein Occlusion (RVO) - Lucentis® (ranibizumab injection))

Rating

Last update: 22.10.2016, 04:39 (update every 3 days)

ip-address that hosts the domain: 72.34.128.116. Name eyeonvegf-a.org refers to 11-character domains. Add your reviews about eyeonvegf-a.org below in the form of.

Domain name:	eyeonvegf-a.org
Name:	Lucentis® (ranibizumab injection) for Wet AMD, Diabetic Macular Edema (DME) & Macular Edema following Retinal Vein Occlusion (RVO) - Lucentis® (ranibizumab injection)
Description:	Find information and data for healthcare professionals about LUCENTIS® (ranibizumab injection) for the rapid and sustained improvement in vision for the treatment of wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. INDICATION LUCENTIS® (ranibizumab injection) is indicated for the treatment of patients with: -Neovascular (wet) age-related macular degeneration (wAMD) -Macular edema following retinal vein occlusion (RVO) -Diabetic macular edema (DME) IMPORTANT SAFETY INFORMATION LUCENTIS is contraindicated in patients with ocular or periocular infections o
Keywords:	Lucentis, ranibizumab, wet amd treatment, wet Age-Related macular degeneration treatment, retinal vein occlusion treatment, macular edema, diabetic macular edema, Age-Related macular degeneration
DNS-server:	dnadns2e.gene.com dnadns4e.gene.com dnadns3e.gene.com
Provider:	AS10725 Genentech, Inc.
Organization:	Genentech
Country:	United States, California, San Francisco
How many characters in domain:	11
IP that hosts the domain:	72.34.128.116 (all sites on this IP)